{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T17:38:47Z","timestamp":1787593127525,"version":"build-2736575974"},"reference-count":19,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1447,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1111\/j.1365-2982.2011.01771.x","type":"journal-article","created":{"date-parts":[[2011,9,16]],"date-time":"2011-09-16T07:51:08Z","timestamp":1316159468000},"page":"1098-1104","source":"Crossref","is-referenced-by-count":61,"title":["Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine"],"prefix":"10.1111","volume":"23","author":[{"given":"K. J.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Y.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. K.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. C.","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. C.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. I.","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. J.","family":"Myung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. J.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. K.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. T.","family":"Bak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. L.","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,9,15]]},"reference":[{"key":"10.1111\/j.1365-2982.2011.01771.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1041-2972.2005.00011.x","article-title":"Recognizing and managing patients with irritable bowel syndrome","volume":"17","author":"Croghan","year":"2005","journal-title":"J Am Acad Nurse Pract"},{"key":"10.1111\/j.1365-2982.2011.01771.x-BIB2|cit2","first-page":"495","article-title":"Prevalence of irritable bowel syndrome: a community survey","volume":"54","author":"Wilson","year":"2004","journal-title":"Br J Gen Pract"},{"key":"10.1111\/j.1365-2982.2011.01771.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/j.1572-0241.2004.04161.x","article-title":"The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an Asian urban community","volume":"99","author":"Gwee","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2982.2011.01771.x-BIB4|cit4","first-page":"1910","article-title":"The epidemiology of irritable bowel syndrome in North America: a systematic review","volume":"97","author":"Saito","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2982.2011.01771.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0140-6736(00)02033-X","article-title":"Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial","volume":"355","author":"Camilleri","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2982.2011.01771.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1365-2982.2003.00389.x","article-title":"Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials","volume":"15","author":"Cremonini","year":"2003","journal-title":"Neurogastroenterol Motil"},{"key":"10.1111\/j.1365-2982.2011.01771.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1001\/archinte.161.14.1733","article-title":"A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome","volume":"161","author":"Camilleri","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1365-2982.2011.01771.x-BIB8|cit8","first-page":"G827","article-title":"Involvement of the 5-HT3 receptor in CRH-induce defecation in rats","volume":"274","author":"Miyata","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1365-2982.2011.01771.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1254\/jphs.FP0071943","article-title":"Inhibitory effects of ramosetron, a potent and selective 5-HT3-receptor antagonist, on conditioned fear stress-induced abnormal defecation and normal defecation in rats: comparative studies with antidiarrheal and spasmolytic agents","volume":"106","author":"Hirata","year":"2008","journal-title":"J Pharmacol Sci"},{"key":"10.1111\/j.1365-2982.2011.01771.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2982.2007.01069.x","article-title":"Effects of serotonin 5-HT3 receptor antagonists on stress-induced colonic hyperalgesia and diarrhoea in rats: a comparative study with opioid receptor agonists, a muscarinic receptor antagonist and a synthetic polymer","volume":"20","author":"Hirata","year":"2008","journal-title":"Neurogastroenterol Motil"},{"key":"10.1111\/j.1365-2982.2011.01771.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000150632","article-title":"A phase II trial of the novel serotonin type 3 receptor antagonist ramosetron in Japanese male and female patients with diarrhea-predominant irritable bowel syndrome","volume":"77","author":"Matsueda","year":"2008","journal-title":"Digestion"},{"key":"10.1111\/j.1365-2982.2011.01771.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1080\/00365520802240255","article-title":"A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome","volume":"43","author":"Matsueda","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"10.1111\/j.1365-2982.2011.01771.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1046\/j.1365-2036.1999.00678.x","article-title":"Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patients","volume":"13","author":"Jones","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2982.2011.01771.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3748\/wjg.v16.i5.547","article-title":"A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome","volume":"16","author":"Darvish-Damavandi","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1365-2982.2011.01771.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2982.2011.01771.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1358\/dot.2002.38.2.820104","article-title":"Ramosetron, a 5-HT3 receptor antagonist for the control of nausea and vomiting","volume":"38","author":"Rabasseda","year":"2002","journal-title":"Drugs Today"},{"key":"10.1111\/j.1365-2982.2011.01771.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00023210-200519030-00004","article-title":"Selective serotonin 5-HT3 receptor antagonists for postoperative nausea and vomiting: are they all the same?","volume":"19","author":"Gan","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1111\/j.1365-2982.2011.01771.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cgh.2007.12.015","article-title":"Effects of 5-HT3 antagonists on symptom relief and constipation in non-constipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials","volume":"6","author":"Andresen","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2982.2011.01771.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.clinthera.2008.05.002","article-title":"Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: A meta-analysis of eight randomized, placebo-controlled, 12-week trials","volume":"30","author":"Rahimi","year":"2008","journal-title":"Clin Ther"}],"container-title":["Neurogastroenterology & Motility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2982.2011.01771.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2982.2011.01771.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T15:38:29Z","timestamp":1625585909000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2982.2011.01771.x"}},"subtitle":["Efficacy of ramosetron in the treatment of IBS male patients"],"short-title":[],"issued":{"date-parts":[[2011,9,15]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2982.2011.01771.x","relation":{},"ISSN":["1350-1925"],"issn-type":[{"value":"1350-1925","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9,15]]}}}